Literature DB >> 25726168

Prognostic factors for local control in patients receiving radiation therapy for early glottic cancer: anterior commissure involvement and effect of chemoradiotherapy.

Yosuke Kitani1, Akira Kubota2, Madoka Furukawa2, Kaname Sato2.   

Abstract

To assess the prognostic factors for local control in patients with early glottic cancer, we retrospectively analyzed the data of 130 consecutive patients who were treated by definitive radiation therapy (RT) or concurrent chemoradiotherapy (CRT) for early glottic squamous cell carcinoma (UICC sixth edition T1N0M0 and T2N0M0) at Kanagawa cancer center between 1999 and 2011. There were 63 patients with T1 cancer and 67 patients with T2 cancer. Twenty-one patients with T2 tumors were treated by chemoradiotherapy (CRT). The median follow-up period was 73 months (range, 22-165 months). The 5-year local control (LC) rate in all patients was 81 %. The 5-year LC rates in the patients with T1 and T2 cancer were 89 and 74 %, respectively. Univariate analysis showed that a higher T stage (T2) (p = 0.0301), anterior commissure involvement (p < 0.000001), and habitual drinking (p = 0.054) were correlated with decreased local control rate. Multivariate analysis identified only anterior commissure involvement as a significant prognostic factor for local control (LC rate 91 vs. 51 %, risk ratio 5.3, 95 % CI 2.3-12, p < 0.001). In the patients with T2 cancer, there was no statistically significant difference in the LC rate between patients who received RT alone and those who received CRT (RT alone 76 % vs. CRT 67 %; p = 0.832). The findings of this study suggest that anterior commissure involvement is a significant factor influencing the prospect of local control. CRT was not found to be effective for T2 patients in this study.

Entities:  

Keywords:  Anterior commissure involvement; Concurrent chemoradiotherapy; Early glottic cancer; Radiotherapy

Mesh:

Year:  2015        PMID: 25726168     DOI: 10.1007/s00405-015-3579-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  38 in total

1.  Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma.

Authors:  Takeshi Nonoshita; Yoshiyuki Shioyama; Katsumasa Nakamura; Torahiko Nakashima; Saiji Ohga; Tadamasa Yoshitake; Kayoko Ohnishi; Kotaro Terashima; Kaori Asai; Hiroshi Honda
Journal:  J Radiat Res       Date:  2010-06-30       Impact factor: 2.724

2.  CO2 laser surgery in the treatment of glottic cancer.

Authors:  Giovanni Motta; Erik Esposito; Sergio Motta; Gianpaolo Tartaro; Domenico Testa
Journal:  Head Neck       Date:  2005-08       Impact factor: 3.147

3.  T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.

Authors:  D A Fein; W M Mendenhall; J T Parsons; R R Million
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-03-15       Impact factor: 7.038

4.  Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients.

Authors:  G Marshak; B Brenner; J Shvero; J Shapira; D Ophir; I Hochman; G Marshak; A Sulkes; E Rakowsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-15       Impact factor: 7.038

5.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05

6.  Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.

Authors:  O Laccourreye; L Muscatello; L Laccourreye; P Naudo; D Brasnu; G Weinstein
Journal:  Am J Otolaryngol       Date:  1997 Nov-Dec       Impact factor: 1.808

Review 7.  [Functional organ preservation in laryngeal and hypopharyngeal cancer].

Authors:  P Ambrosch; A Fazel
Journal:  Laryngorhinootologie       Date:  2011-04-26       Impact factor: 1.057

8.  T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy.

Authors:  W M Mendenhall; R J Amdur; C G Morris; R W Hinerman
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

9.  Vertical partial laryngectomy: a critical analysis of local recurrence.

Authors:  O Laccourreye; G Weinstein; D Brasnu; J Trotoux; H Laccourreye
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-01       Impact factor: 1.547

10.  Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival.

Authors:  J Overgaard; H S Hansen; K Jørgensen; M Hjelm Hansen
Journal:  Int J Radiat Oncol Biol Phys       Date:  1986-04       Impact factor: 7.038

View more
  8 in total

1.  Clinical Application Study of Semi-cylindrical Beam Spoiler for Radiation Treatment of Early-stage Glottic Cancer Patients.

Authors:  So Hyun Ahn; Woo Sang Ahn; Dong Hyeok Choi; Seong Soo Shin; Jin Sung Kim
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Impact of Close and Positive Margins in Transoral Laser Microsurgery for Tis-T2 Glottic Cancer.

Authors:  Ivana Fiz; Francesco Mazzola; Francesco Fiz; Filippo Marchi; Marta Filauro; Alberto Paderno; Giampiero Parrinello; Cesare Piazza; Giorgio Peretti
Journal:  Front Oncol       Date:  2017-10-16       Impact factor: 6.244

3.  Impact of the anterior commissure involvement on the survival of early glottic cancer treated with cricohyoidoepiglottopexy: a retrospective study.

Authors:  Eugenia Allegra; Vincenzo Saita; Alfio Azzolina; Massimo De Natale; Maria Rita Bianco; Domenico Michele Modica; Aldo Garozzo
Journal:  Cancer Manag Res       Date:  2018-11-08       Impact factor: 3.989

Review 4.  Prognostic factors in laryngeal squamous cell carcinoma.

Authors:  Carol R Bradford; Alfio Ferlito; Kenneth O Devaney; Antti A Mäkitie; Alessandra Rinaldo
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-01-27

5.  Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.

Authors:  You Zhang; Tsuicheng Chiu; Jeffrey Dubas; Zhen Tian; Pam Lee; Xuejun Gu; Yulong Yan; David Sher; Robert Timmerman; Bo Zhao
Journal:  Radiat Oncol       Date:  2019-11-04       Impact factor: 3.481

6.  Analysis of prognostic factors for Tis-2N0M0 early glottic cancer with different treatment methods.

Authors:  Guanyu Wang; Guodong Li; Jianjun Wu; Penghui Song
Journal:  Braz J Otorhinolaryngol       Date:  2020-08-06

7.  Survival and Prognostic Factors for Outcome after Radiotherapy for T2 Glottic Carcinoma.

Authors:  Martine Hendriksma; Marc A P van Ruler; Berit M Verbist; Martin A de Jong; Ton P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

8.  Outcome of Early-Stage Glottic Laryngeal Carcinoma Patients Treated with Radical Radiotherapy Using Different Techniques.

Authors:  Oguz Cetinayak; Ersoy Dogan; Ahmet Kuru; Nesrin Akturk; Barbaros Aydin; Cenk Umay; Ilhami Er; Fadime Akman
Journal:  J Oncol       Date:  2019-11-06       Impact factor: 4.375

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.